• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患儿肠道微生物能量与代谢的改变

Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.

作者信息

Michail Sonia, Lin Malinda, Frey Mark R, Fanter Rob, Paliy Oleg, Hilbush Brian, Reo Nicholas V

机构信息

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition at Children's Hospital Los Angeles, 4650 Sunset Blvd. MS#78, Los Angeles, CA 90027, USA Keck School of Medicine at the University of Southern California, Los Angeles, CA 90089, USA

Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition at Children's Hospital Los Angeles, 4650 Sunset Blvd. MS#78, Los Angeles, CA 90027, USA Keck School of Medicine at the University of Southern California, Los Angeles, CA 90089, USA.

出版信息

FEMS Microbiol Ecol. 2015 Feb;91(2):1-9. doi: 10.1093/femsec/fiu002. Epub 2014 Dec 5.

DOI:10.1093/femsec/fiu002
PMID:25764541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4358749/
Abstract

Obesity is becoming the new pediatric epidemic. Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and has become the most common cause of pediatric liver disease. The gut microbiome is the major metabolic organ and determines how calories are processed, serving as a caloric gate and contributing towards the pathogenesis of NAFLD. The goal of this study is to examine gut microbial profiles in children with NAFLD using phylogenetic, metabolomic, metagenomic and proteomic approaches. Fecal samples were obtained from obese children with or without NAFLD and healthy lean children. Stool specimens were subjected to 16S rRNA gene microarray, shotgun sequencing, mass spectroscopy for proteomics and NMR spectroscopy for metabolite analysis. Children with NAFLD had more abundant Gammaproteobacteria and Prevotella and significantly higher levels of ethanol, with differential effects on short chain fatty acids. This group also had increased genomic and protein abundance for energy production with a reduction in carbohydrate and amino acid metabolism and urea cycle and urea transport systems. The metaproteome and metagenome showed similar findings. The gut microbiome in pediatric NAFLD is distinct from lean healthy children with more alcohol production and pathways allocated to energy metabolism over carbohydrate and amino acid metabolism, which would contribute to development of disease.

摘要

肥胖正成为新的儿科流行病。非酒精性脂肪性肝病(NAFLD)常与肥胖相关,已成为儿科肝病最常见的病因。肠道微生物群是主要的代谢器官,决定了卡路里的处理方式,充当热量闸门并促成NAFLD的发病机制。本研究的目的是使用系统发育、代谢组学、宏基因组学和蛋白质组学方法检查NAFLD儿童的肠道微生物谱。从患有或未患有NAFLD的肥胖儿童以及健康的瘦儿童中获取粪便样本。粪便标本进行16S rRNA基因微阵列、鸟枪法测序、蛋白质组学质谱分析和代谢物分析的核磁共振光谱分析。患有NAFLD的儿童γ-变形菌和普雷沃菌更为丰富,乙醇水平显著更高,对短链脂肪酸有不同影响。该组能量产生的基因组和蛋白质丰度也增加,碳水化合物和氨基酸代谢以及尿素循环和尿素转运系统减少。宏蛋白质组和宏基因组显示出类似的结果。儿科NAFLD中的肠道微生物群与健康瘦儿童不同,产生更多酒精,能量代谢途径多于碳水化合物和氨基酸代谢途径,这将有助于疾病的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18ee/4447788/c8c66d9f91e8/fiu002fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18ee/4447788/c8c66d9f91e8/fiu002fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18ee/4447788/c8c66d9f91e8/fiu002fig1g.jpg

相似文献

1
Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患儿肠道微生物能量与代谢的改变
FEMS Microbiol Ecol. 2015 Feb;91(2):1-9. doi: 10.1093/femsec/fiu002. Epub 2014 Dec 5.
2
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.与儿童非酒精性脂肪性肝病患者的脂肪性肝炎和中重度纤维化相关的微生物组特征。
Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.
3
Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.肠道菌群在儿童非酒精性脂肪性肝病发病机制中的作用。
Microbiol Spectr. 2024 Feb 6;12(2):e0100623. doi: 10.1128/spectrum.01006-23. Epub 2024 Jan 8.
4
A metagenomic study identifies a Prevotella copri enriched microbial profile associated with non-alcoholic steatohepatitis in subjects with obesity.一项宏基因组学研究鉴定出与肥胖人群非酒精性脂肪性肝炎相关的富含普雷沃氏菌属的微生物特征。
J Gastroenterol Hepatol. 2023 May;38(5):791-799. doi: 10.1111/jgh.16147. Epub 2023 Mar 2.
5
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.非酒精性脂肪性肝病的严重程度与肠道菌群失调及肠道微生物群代谢功能的改变有关。
Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.
6
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.了解肠道微生物组和微生物代谢物在非酒精性脂肪性肝病中的作用:当前的证据和观点。
Biomolecules. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056.
7
Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.整合代谢组学强调肠道微生物群代谢物作为儿童非酒精性脂肪性肝病相关的新型候选生物标志物。
Microbiol Spectr. 2024 Apr 2;12(4):e0523022. doi: 10.1128/spectrum.05230-22. Epub 2024 Mar 6.
8
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
9
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道菌群失调。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5.
10
Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression.肠道微生物谱的改变伴随着异常的短链脂肪酸代谢会加剧非酒精性脂肪性肝病的进展。
Sci Rep. 2024 Sep 27;14(1):22385. doi: 10.1038/s41598-024-72909-8.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Gut microbiota-derived 4-hydroxyphenylacetic acid (4-HPAA) inhibits weight gain and is negatively associated with childhood obesity.肠道微生物群衍生的4-羟基苯乙酸(4-HPAA)可抑制体重增加,且与儿童肥胖呈负相关。
Transl Pediatr. 2025 Jun 27;14(6):1156-1167. doi: 10.21037/tp-2025-158. Epub 2025 Jun 25.
3

本文引用的文献

1
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism.短链脂肪酸乙酸盐通过一种中枢稳态机制降低食欲。
Nat Commun. 2014 Apr 29;5:3611. doi: 10.1038/ncomms4611.
2
Gut microbiota from twins discordant for obesity modulate metabolism in mice.肥胖症双胞胎的肠道微生物群可调节小鼠的代谢。
Science. 2013 Sep 6;341(6150):1241214. doi: 10.1126/science.1241214.
3
Microbiology. Fighting obesity with bacteria.微生物学。利用细菌对抗肥胖。
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.
代谢功能障碍相关脂肪性肝病及相关肝细胞癌中的肠道微生物群
Nat Rev Gastroenterol Hepatol. 2025 Jul 7. doi: 10.1038/s41575-025-01089-1.
4
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
5
Non-alcoholic fatty liver disease enhances the beneficial effect of renal denervation on gut microbiota aberrations in rats with heart failure.非酒精性脂肪性肝病增强了肾去神经支配对心力衰竭大鼠肠道微生物群异常的有益作用。
BMC Microbiol. 2025 May 21;25(1):311. doi: 10.1186/s12866-025-04027-y.
6
Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH.对患有MASLD或MASH的肥胖儿童肠道微生物群进行鸟枪法测序的荟萃分析。
Gut Microbes. 2025 Dec;17(1):2508951. doi: 10.1080/19490976.2025.2508951. Epub 2025 May 21.
7
Intestinal Microbiota Modulation by Fecal Microbiota Transplantation in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中粪便微生物群移植对肠道微生物群的调节作用
Biomedicines. 2025 Mar 23;13(4):779. doi: 10.3390/biomedicines13040779.
8
Role of Gut-Liver Axis in Non-Alcoholic Fatty Liver Disease.肠-肝轴在非酒精性脂肪性肝病中的作用
Iran Biomed J. 2025 Jan 1;29(1 & 2):1-8. doi: 10.61186/ibj.4212.
9
Multi-site investigation of gut microbiota in CDKL5 deficiency disorder mouse models: Targeting dysbiosis to improve neurological outcomes.CDKL5缺陷障碍小鼠模型中肠道微生物群的多中心研究:针对生态失调改善神经学结局。
Cell Rep. 2025 Apr 22;44(4):115546. doi: 10.1016/j.celrep.2025.115546. Epub 2025 Apr 10.
10
Lactiplantibacillus plantarum FRT4 protects against fatty liver hemorrhage syndrome: regulating gut microbiota and FoxO/TLR-4/NF-κB signaling pathway in laying hens.植物乳杆菌FRT4可预防脂肪肝出血综合征:调节蛋鸡肠道微生物群及FoxO/TLR-4/NF-κB信号通路
Microbiome. 2025 Mar 29;13(1):88. doi: 10.1186/s40168-025-02083-0.
Science. 2013 Sep 6;341(6150):1069-70. doi: 10.1126/science.1243787.
4
Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者全因死亡率和肝脏相关死亡率的预测因素。
Dig Dis Sci. 2013 Oct;58(10):3017-23. doi: 10.1007/s10620-013-2743-5. Epub 2013 Jun 18.
5
Intestinal microbiota in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道微生物群。
Hepatology. 2013 Jul;58(1):120-7. doi: 10.1002/hep.26319. Epub 2013 May 14.
6
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.肠道微生物群决定了小鼠非酒精性脂肪肝病的发展。
Gut. 2013 Dec;62(12):1787-94. doi: 10.1136/gutjnl-2012-303816. Epub 2012 Nov 29.
7
Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.非酒精性脂肪性肝炎(NASH)患者肠道微生物组的特征:内源性酒精与 NASH 之间的联系。
Hepatology. 2013 Feb;57(2):601-9. doi: 10.1002/hep.26093. Epub 2013 Jan 8.
8
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.
9
Systematic comparisons of various spectrophotometric and colorimetric methods to measure concentrations of protein, peptide and amino acid: detectable limits, linear dynamic ranges, interferences, practicality and unit costs.系统比较各种分光光度法和比色法测定蛋白质、肽和氨基酸浓度的方法:检测限、线性动态范围、干扰、实用性和单位成本。
Talanta. 2012 Aug 30;98:123-9. doi: 10.1016/j.talanta.2012.06.058. Epub 2012 Jun 30.
10
Metabolic reconstruction for metagenomic data and its application to the human microbiome.宏基因组数据的代谢重建及其在人类微生物组中的应用。
PLoS Comput Biol. 2012;8(6):e1002358. doi: 10.1371/journal.pcbi.1002358. Epub 2012 Jun 13.